G. Motte

发表

Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

E. M. Passos, L. Duflot, M. Brahimi, 2020, Kidney International.

Management of anticancer treatment in patients under chronic dialysis: results of the multicentric CANDY (CANcer and DialYsis) study.

J. Thariat, L. Juillard, G. Deray, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study.

R. Gibey, B. Challier, D. Ducloux, 2000, Journal of the American Society of Nephrology : JASN.

Determinants of mean arterial pressure and pulse pressure in chronic haemodialysis patients

D. Ducloux, G. Motte, J. Chalopin, 2001, Journal of Human Hypertension.

Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12.

G. Toubin, Z. Massy, T. Drüeke, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Homocysteine, nutritional status and insulin in renal transplant recipients.

R. Gibey, D. Ducloux, J. Chalopin, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Antiphospholipid antibodies as a risk factor for atherosclerotic events in renal transplant recipients.

D. Ducloux, J. Chalopin, G. Motte, 2003, Kidney international.

Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2‐year follow‐up

C. Billerey, D. Ducloux, C. Bresson‐Vautrin, 2002 .

Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up

C. Billerey, D. Ducloux, C. Bresson‐Vautrin, 2002, Transplant international : official journal of the European Society for Organ Transplantation.

LONG-TERM TOXICITY OF ANTITHYMOCYTE GLOBULIN INDUCTION MAY VARY WITH CHOICE OF AGENT: A SINGLE-CENTER RETROSPECTIVE STUDY

A. Kazory, B. Challier, D. Ducloux, 2004, Transplantation.

Hypertension in renal transplantation: donor and recipient risk factors.

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 2002, Clinical nephrology.

Lymphocyte subsets and assessment of cancer risk in renal transplant recipients

P. Tiberghien, P. Carron, D. Ducloux, 2002, Transplant international : official journal of the European Society for Organ Transplantation.

Polycystic kidney disease as a risk factor for post-transplant diabetes mellitus.

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Management of anticancer treatment in patients under chronic dialysis: results of the multicentric CANDY (CANcer and DialYsis) study.

J. Thariat, L. Juillard, G. Deray, 2013 .

Homocysteine in renal disease.

D. Ducloux, J. Chalopin, G. Motte, 2000, Clinical Laboratory.

Vitamin E-coated dialyzer reduces oxidative stress in hemodialysis patients.

L. Rochette, J. Guilland, G. Clermont, 2001, Free radical biology & medicine.

Treatment of hyperhomocysteinemia with folic acid reduces oxidative stress in renal transplant recipients.

G. Toubin, Aboubakr Abdelfatah, Didier Ducloux, 2002, Transplantation.